返回
The Computational Drug Repositioning Without Negative Sampling
DOI:10.1109/TCBB.2022.3212051.png)
摘要
En 中文
Computational drug repositioning technology is an effective tool to accelerate drug development. Although this technique has been widely used and successful in recent decades, many existing models still suffer from multiple drawbacks such as the massive number of unvalidated drug-disease associations and the inner product. The limitations of these works are mainly due to the following two reasons: firstly, previous works used negative sampling techniques to treat unvalidated drug-disease associations as negative samples, which is invalid in real-world settings; secondly, the inner product cannot fully take into account the feature information contained in the latent factor of drug and disease. In this paper, we propose a novel PUON framework for addressing the above deficiencies, which models the risk estimator of computational drug repositioning only using validated (Positive) and unvalidated (Unlabelled) drug-disease associations without employing negative sampling techniques. The PUON also proposed an Outer Neighborhood-based classifier for modeling the cross-feature information of the latent facotor. For a comprehensive comparison, we considered 6 popular baselines. Extensive experiments in four real-world datasets showed that PUON model achieved the best performance based on 6 evaluation metrics.
Keyword:
Drugs
Diseases
Computational modeling
Predictive models
Collaboration
Training
Shape
Drug discovery
computational drug repositioning
outer product
positive-unlabeled learning
期刊
I
IF:
3.4
论文数:
3.3K
被引数:
6.4K
机构
引用论文
Seismic anisotropy indicates organized melt beneath the Mid-Atlantic Ridge aids seafloor spreading
Geology
IF0
SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules微笑,一种化学语言和信息系统。1.介绍方法和编码规则
Computational drug repositioning based on the relationships between substructure-indication基于子结构指示之间关系的计算药物重新定位

